Anao, I; Houghton, P; Croft, S; (2004) Antiprotozoal activity guided fractionation of Sclerocarya birrea (A. Rich.) Hochst. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/6181 Full text not available from this repository.

Dos Santos, DAP; Braga, PAD; da Silva, M; Fernandes, JB; Vieira, PC; Magalhaes, AF; Magalhaes, EG; Marsaioli, AJ; Moraes, VRD; Rattray, L; +1 more... Croft, SL; (2009) Anti-African trypanocidal and antimalarial activity of natural flavonoids, dibenzoylmethanes and synthetic analogues. The Journal of pharmacy and pharmacology, 61 (2). pp. 257-266. ISSN 0022-3573 DOI: https://doi.org/10.1211/jpp/61.02.0017 Full text not available from this repository.

Garnier, T; Brown, MB; Lawrence, MJ; Croft, SL; (2006) In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis. The Journal of pharmacy and pharmacology, 58 (8). pp. 1043-54. ISSN 0022-3573 DOI: https://doi.org/10.1211/jpp.58.8.0004 Full text not available from this repository.

Garnier, T; Mäntylä, A; Järvinen, T; Lawrence, MJ; Brown, MB; Croft, SL; (2007) Topical buparvaquone formulations for the treatment of cutaneous leishmaniasis. The Journal of pharmacy and pharmacology, 59 (1). pp. 41-9. ISSN 0022-3573 DOI: https://doi.org/10.1211/jpp.59.1.0006 Full text not available from this repository.

Cuccui, J; Wren, B; (2014) Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins. The Journal of pharmacy and pharmacology. ISSN 0022-3573 DOI: https://doi.org/10.1111/jphp.12321

Van Bocxlaer, K; Yardley, V; Murdan, S; Croft, SL; (2016) Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model. The Journal of pharmacy and pharmacology, 68 (7). pp. 862-72. ISSN 0022-3573 DOI: https://doi.org/10.1111/jphp.12548